Related Experiment Video
Updated: Mar 2, 2026
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Renal Function Considerations for Stroke Prevention in Atrial Fibrillation
John Fanikos1, Allison E Burnett2, Charles E Mahan3
1Department of Pharmacy, Brigham and Women's Hospital, Boston, Mass.
Insights
Direct oral anticoagulants (DOACs) offer a favorable risk-benefit profile for atrial fibrillation patients with mild to moderate renal impairment compared to warfarin. Careful monitoring is crucial due to varied renal elimination.
Area of Science:
- Cardiology
- Nephrology
- Pharmacology
Background:
- Renal impairment elevates risks of stroke, systemic embolism, and bleeding in atrial fibrillation (AF) patients.
- Direct oral anticoagulants (DOACs) exhibit varying degrees of renal elimination, necessitating precise patient selection, dosing, and monitoring.
- Warfarin has been the traditional anticoagulant, but its use requires frequent monitoring and dietary considerations.
Purpose of the Study:
- To evaluate the efficacy and safety of DOACs compared to warfarin in nonvalvular atrial fibrillation (NVAF) patients with varying degrees of renal function.
- To assess the risk-benefit profile of DOACs in NVAF patients experiencing declining renal function over time.
- To highlight the importance of kidney function assessment in guiding anticoagulant therapy selection.
Main Methods:
- Analysis of data from randomized controlled trials (RCTs) involving NVAF patients treated with DOACs versus warfarin.
- Stratification of patients based on renal function (mild, moderate, severe impairment, and dialysis).
- Comparison of key outcomes including stroke, systemic embolic events, and major bleeding between treatment groups.
Main Results:
- DOACs demonstrated at least equivalent efficacy to warfarin in preventing stroke and systemic embolic events in NVAF patients.
- DOACs were associated with significantly less bleeding compared to warfarin across all evaluated renal function categories.
- DOACs showed a reduced risk of stroke, systemic embolic events, and major bleeding compared to warfarin in patients with mild or moderate renal impairment.
Conclusions:
- DOACs represent a safer and effective alternative to warfarin for NVAF patients with mild to moderate renal impairment.
- The risk-benefit profile of DOACs appears favorable in patients with decreasing renal function.
- Further research is needed to establish the optimal use of DOACs in patients with severe renal impairment or on dialysis.
Abstract:
Renal impairment increases risk of stroke and systemic embolic events and bleeding in patients with atrial fibrillation. Direct oral anticoagulants (DOACs) have varied dependence on renal elimination, magnifying the importance of appropriate patient selection, dosing, and periodic kidney function monitoring. In randomized controlled trials of nonvalvular atrial fibrillation, DOACs were at least as effective and associated with less bleeding compared with warfarin. Each direct oral anticoagulant was associated with reduced risk of stroke and systemic embolic events and major bleeding compared with warfarin in nonvalvular atrial fibrillation patients with mild or moderate renal impairment. Renal function decrease appears less impacted by DOACs, which are associated with a better risk-benefit profile than warfarin in patients with decreasing renal function over time. Limited data address the risk-benefit profile of DOACs in patients with severe impairment or on dialysis.
More Related Videos
28:13Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
08:10Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Related Concept Videos
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
01:23Atherosclerosis IV: Nursing Management
01:22Acute Kidney Injury VI: Nursing Management
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:11Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...